The Latest Breaking News from Pfizer

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

Time is running out for free-to-consumer COVID-19 vaccines, at-home test kits and some treatments.

With Russia’s plans to cut crude oil production threatening to tip an interest-rate-paranoid market into a fresh bout of volatility and sell-off, shares of fundamentally strong and profitable businesses, such as Taiwan Semiconductor Manufacturing Company (TSM), Walmart (WMT), and Pfizer (PFE), seem to be good investments now. Continue reading….

Social media users shared a range of false claims this week

Republicans have opened a new inquiry with a brazen attempt to portray the federal government as weaponized against Americans

A committee hearing held as payback for probes into Donald Trump quickly devolved

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance